What AlloSource does

AlloSource is a nonprofit human tissue processor founded in 1994 in Centennial, Colorado, by three Organ Procurement Organizations (Donor Alliance, Gift of Hope Organ & Tissue Donor Network, and Iowa Donor Network). It transforms donated human tissue into allograft products across 11 tissue types — dermis, cartilage, tendon, fascia, bone, and amnion — serving 8 surgical specialties including orthopedics, sports medicine, spine, plastics and reconstruction, urogynecology, burn and wound care, and foot and ankle. The company is governed by a board composed of OPO executives, with no external PE or VC ownership, and operates from a 160,000-square-foot headquarters containing 37 clean rooms and multiple laboratory spaces.

AlloSource's product platform rests on three proprietary processing technologies: ViaTrue Cryopreservation (controlled-rate freezing of fresh cartilage within 72 hours of donor death, maintaining high chondrocyte viability for up to two years), AlloTrue Tissue Cleansing (deep-tissue cleansing that removes blood and lipids while preserving biomechanical properties), and DermaTrue Decellularization (which removes cellular debris to render tissue acellular while preserving native collagen structure). Products such as AlloMend are terminally sterilized with e-beam technology to a Sterility Assurance Level of 10^-6. The company holds 100+ patents across these processes and has recorded zero confirmed disease transmission incidents over 20+ years of processing, with an estimated transmission risk below 1 in 1.6 million. Differentiated pre-sutured ready-to-use devices (AceConnex for hip labral reconstruction, ReConnex for ACL reconstruction) eliminate 24-45 minutes of OR preparation time.

AlloSource generates revenue by processing and distributing allograft products to hospitals, surgery centers, and orthopedic practices. Distribution is handled through an independent distributor network and a field-based direct sales team, supported by nine regional distribution centers across the United States and contracts with all national GPOs and hundreds of integrated delivery networks. International distribution extends to the Asia Pacific Rim, EU, Latin America, and South America under Health Canada, EU tissue directive, Korean, and Taiwan FDA compliance. Pricing is not publicly disclosed; hospital purchasing terms include annual CPI-linked price adjustment caps. The company employs more than 500 people and distributes more than 200,000 allografts annually (up from approximately 14,000 in 1994), with key leadership including President and CEO Dean Elliott, CFO Yan Deng, and Chief Commercial Officer Kevin Whitten.

Name

AlloSource

Legal name

AlloSource

Website

https://allosource.org

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

501–1,000 employees

Short description

AlloSource is a nonprofit human tissue processor that transforms donated tissue into 200,000+ allograft products annually across 11 tissue types and 8 surgical specialties, serving hospitals, surgery centers, and orthopedic practices in the US and internationally through direct sales and distributors.

Ownership category

akta.pro rank

Product category

Human Tissue Allografts

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Biological Products, (No Disgnostic Substances) (2836), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)

Keywords

• Human tissue allografts
• Acellular dermal matrix
• Orthopedic tissue products
• Bone grafting materials
• Tissue banking services

Headquarters

HQ city

Centennial

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Human Tissue Allograft Products: AlloSource generates revenue by processing and distributing human tissue allografts (dermis, cartilage, tendon, fascia, bone, and amnion) to hospitals, surgery centers, and orthopedic surgeons for use in various surgical procedures including knee replacement, bone grafts, spinal fusions, eye surgery, and skin grafts.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

AlloSource processes donated human tissue into allograft products for surgical use, offering a comprehensive portfolio of dermis, cartilage, tendon, fascia, bone, and amnion allografts serving orthopedics, sports medicine, spine, plastics/reconstruction, urogynecology, burn, and wound care specialties. Products are developed using proprietary processing technologies including ViaTrue cryopreservation, AlloTrue cleansing, and DermaTrue decellularization, and are distributed to hospitals, surgery centers, and orthopedic practices.

Product overview

AlloSource is one of the largest human tissue providers, offering a comprehensive portfolio of innovative allograft products derived from donated human tissue. The portfolio includes multiple product lines organized by tissue type: Acellular Dermal Matrix products (AlloMend line with variants including Duo, Ultra Thick, Extra-Large, and Mesh Shaped), Skin products (AlloSkin, PureSkin), Cartilage products (ProChondrix CR, Costal Cartilage), Bone products (AlloFuse line including Select, Cervical Spacers, Fibers, Paste/Putty/Gel; Cortical/Cancellous Bone, Structural Bone, Reconstructive Bone), Tendon/Ligament products (AlloConnex portfolio including ReConnex Pre-Sutured Tendon, AceConnex Pre-Sutured Fascia), Fascia products (UroConnex), and Amnion products (AlloWrap). Products serve multiple surgical specialties including burn care, foot & ankle, orthopedics, plastics/reconstruction, spine, sports medicine, urogynecology, and wound care.

Differentiator

Problem solved

Functional benefit

Brands

• AceConnex: Pre-Sutured Fascia product line for hip labral reconstruction
• AlloConnex
• AlloFlex
• AlloFuse
• AlloMend
• AlloSkin
• AlloWrap
• ProChondrix CR
• PureSkin
• ReConnex
• UroConnex

Products and services

• ReConnex Pre-Sutured Tendon FDA 510(k) cleared ready-to-use sterile pre-sutured tendon allograft designed for all-inside Anterior Cruciate Ligament (ACL) reconstruction procedures. Features validated suture and knot pull-out strength with diameters 8.0-10.5mm and lengths 66mm +/-4mm.
• UroConnex Fascia allograft offered in freeze-dried and frozen varieties with a wide range of sizes for structural support in surgical procedures. Provides an alternative to autologous fascia with terminal sterilization (irradiated to SAL of 10-6).
• AceConnex Pre-Sutured Fascia Only 510(k) cleared pre-sutured fascia allograft for hip labral reconstruction and augmentation. Ready-to-use sterile device that saves 24-45 minutes by eliminating pre-operative manual allograft preparation. Available in three trimmable lengths and two diameter options.
• AlloConnex Tendons, Ligaments & Fascia Portfolio of tendons, ligaments, and fascia allografts processed with AlloTrue tissue cleansing process and terminal sterilization for sports medicine procedures.
• AlloFlex Flexible Bone Matrix Flexible bone matrix product for orthopedic applications.
• AlloFuse Select Cellular Bone Matrix Cellular allograft in a moldable matrix indicated for general bone grafting in orthopedic and spinal fusion procedures. Delivers osteoconductive, osteoinductive, and osteogenic properties. Available in 1cc, 5cc, and 10cc vials.
• AlloFuse Cervical Spacers Cortical and cortical/cancellous bone spacers for spinal fusion procedures.
• AlloFuse Fibers & Fiber Boats Demineralized bone matrix products in fiber and fiber boat formats.
• AlloFuse Paste, Putty & Gel Demineralized bone matrix in paste, putty, and gel formulations for bone grafting applications.
• AlloMend Acellular Dermal Matrix Flexible acellular dermal matrix with ultimate tensile strength exceeding leading competitors. Features terminal sterilization with e-beam technology to SAL of 10-6. Processed with proprietary DermaTrue Decellularization Process. Available in multiple thicknesses and sizes.
• AlloMend Duo Acellular Dermal Matrix Acellular dermal matrix variant for demanding soft tissue repair and reconstruction applications.
• AlloSkin Split-Thickness Dermis Split-thickness dermis allograft for burn and wound care applications.
• AlloSkin AC Acellular Dermal Substrate Acellular dermal substrate for regenerative medicine applications.
• AlloWrap Amniotic Membrane Amniotic membrane allograft for wound care and surgical applications.
• Cortical/Cancellous Bone Bone allograft products including cortical and cancellous bone for orthopedic and spinal applications.
• Costal Cartilage Cartilage allograft derived from costal (rib) cartilage for reconstructive procedures.
• ProChondrix CR Cryopreserved Osteochondral Allograft Cryopreserved osteochondral allograft processed with ViaTrue Cryopreservation Process for knee cartilage repair. Maintains high chondrocyte viability for up to two years.
• PureSkin Dermal Tissue Dermis allograft for plastic and reconstructive surgery applications.
• Reconstructive Bone Bone allograft for reconstructive surgical procedures.
• Structural Bone Structural bone allograft for load-bearing orthopedic applications.

Quantifiable outcome

• Zero confirmed disease transmission incidents in over 20 years of tissue processing
• +5 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Donor AlliancecoreOthersDonor Alliance is one of three founding OPO members that established AlloSource in 1994. Based in Denver, CO, Donor Alliance works collaboratively with AlloSource to maximize tissue donation and its benefits, recovering tissue from donors for processing into AlloSource allograft products.
• Gift of Hope Organ & Tissue Donor NetworkcoreOthersGift of Hope is a founding OPO member of AlloSource, based in Chicago, IL. The organization recovers tissue from donors and works collaboratively with AlloSource to maximize the impact of tissue donation for patients in need.
• Iowa Donor NetworkcoreOthersIowa Donor Network is a founding OPO member of AlloSource, based in North Liberty, IA. The organization serves as a true partner working collaboratively with AlloSource to maximize tissue donation and benefits.
• Mid-America TransplantcoreOthersMid-America Transplant is a founding OPO member of AlloSource, based in St. Louis, MO. The organization collaborates with AlloSource to maximize tissue donation outcomes and benefits to patients.
• ConnectLifecoreOthersConnectLife is a founding OPO member of AlloSource, based in Buffalo, NY. As a true partner, ConnectLife works collaboratively with AlloSource to maximize tissue donation and its benefits.
• Network For HopeminorOthersNetwork For Hope is a recovery partner OPO based in Cincinnati, OH, working with AlloSource to support tissue donation recovery operations.
• LifeLinkminorOthersLifeLink is a recovery partner OPO based in Tampa, FL, supporting AlloSource's tissue donation recovery network.
• Lifesharing Community Organ & Tissue DonationminorOthersLifesharing is a recovery partner OPO based in San Diego, CA, supporting AlloSource's tissue donation recovery network.
• Colorado State University - Orthopaedic Research CenterminorStrategic or Co-development PartnerAlloSource collaborated with Colorado State University's Orthopaedic Research Center (directed by Dr. Laurie Goodrich) on research comparing cryopreserved vs. fresh osteochondral allografts. The study found no significant difference between storage conditions, indicating cryopreservation is a promising alternative to fresh grafting practices.
• National Institute of Health (NIH)minorOthersAlloSource serves as co-applicant for grant awards through the National Institute of Health as part of its sponsored investigator award program and grant co-application initiatives.
• Department of Defense (DoD)minorOthersAlloSource serves as co-applicant for grant awards through the Department of Defense, supporting research into human tissue applications for military medicine and trauma care.
• National Science Foundation (NSF)minorOthersAlloSource participates as co-applicant for grant awards through the National Science Foundation and serves as contractor for small business awards as part of its innovation and research support programs.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• MiMedx: MiMedx is a for-profit regenerative medicine company specializing in amniotic membrane and placental tissue allografts (EpiFix, AmnioFix). It directly competes with AlloSource's AlloWrap and other soft tissue allograft lines in wound care and surgical applications.
• LifeNet Health: LifeNet Health is a nonprofit allograft provider offering dermal, bone, tendon, and cardiovascular tissue products with proprietary processing technologies. Directly comparable to AlloSource in serving hospitals and surgeons with processed human tissue allografts.
• MTF Biologics: MTF Biologics is one of the largest nonprofit tissue banks in the US, processing donated human tissue into allografts for orthopedics, sports medicine, and wound care. It is the closest direct peer to AlloSource in scale, nonprofit structure, and product portfolio breadth.
• Organogenesis: Organogenesis manufactures regenerative medicine products including skin substitutes (Apligraf), wound care devices, and surgical biologics. It overlaps with AlloSource's AlloSkin/PureSkin lines in burn/wound care and competes in adjacent regenerative medicine categories.

Broad incumbents

• Smith+Nephew: Smith+Nephew is a global medical device company with sports medicine and advanced wound management divisions that overlap with AlloSource's orthopedic allografts and skin substitute lines. A broad incumbent rather than a tissue-focused specialist.
• Stryker: Stryker is a major orthopedic medical device company whose sports medicine and biologics offerings overlap with AlloSource's orthopedic allograft lines. Competes across multiple specialties as part of a broad medtech portfolio rather than as a tissue specialist.
• Arthrex: Arthrex is a privately-held leader in sports medicine and orthopedics offering a broad portfolio that includes biologic/sports medicine allografts and procedural solutions. Overlaps with AlloSource in sports medicine allografts as part of a much wider orthopedic device portfolio.
• Medtronic: Medtronic is a diversified medical device leader whose spine and biologics divisions overlap with AlloSource's AlloFuse bone matrix and spinal fusion allograft products. Serves the same hospital call points as part of a much broader portfolio.
• Conmed: Conmed is a medical device company with sports medicine and general surgery offerings that overlap with AlloSource's orthopedic and soft tissue allograft lines. A broad incumbent across multiple surgical specialties.
• Integra LifeSciences: Integra LifeSciences is a public medical device company with a significant regenerative tissue technologies segment (Integra Dermal Regeneration Template, etc.). It competes with AlloSource in dermal matrices and regenerative wound care as part of a diversified neurosurgery and orthopedics portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/AlloSource
• LinkedInlinkedin.com/company/allosource

Compliance23 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AlloSource